The non-profit organization Cancro Primo Aiuto has acquired the MS humanAId platform, developed by EMME ESSE, a synbrAIn partner, to donate it to ASST Brianza, enabling its deployment in additional hospitals across Lombardy.

With MS humanAId, radiologists will have access to a range of innovative AI-based diagnostic tools, developed with synbrAIn’s support. In particular, the AID PNEUMO module of MS humanAId will allow for more effective and rapid early diagnosis, using machine learning techniques capable of detecting lung diseases (including COVID-19-related conditions). This AI-assisted system will help physicians distinguish between different pathologies and facilitate comparisons with similar cases.

During the presentation event (video available at the bottom of this page), Marco Trivelli, General Director of ASST Brianza, expressed great satisfaction with the introduction of this new technology in Brianza’s hospitals:

“This is an early diagnosis software that will help and speed up the work of our radiologists.”

MS humanAId is now being implemented in multiple hospitals.

“Our product was born here in Brianza during the health emergency,” recalls Elisa Mattavelli, CEO of EMME ESSE, “with the goal of creating something useful, concrete, and effective. MS HUMANAIID was designed with this mission in mind, and we are thrilled to see it being deployed here in Brianza, where our company has its deepest roots.”

synbrAIn continues to focus on developing new AI modules, many of which will be integrated into MS humanAId, further reinforcing the existing partnership with EMME ESSE and Mynd. This collaboration has resulted in a unique and innovative product.

Our goal remains to provide effective tools that support daily medical practice, ensuring seamless cooperation between humans and machines—the essence of human-machine cooperation.